Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;38(12):2573-2584.
doi: 10.1038/s41375-024-02455-9. Epub 2024 Nov 2.

Transcriptional regulatory program controlled by MYB in T-cell acute lymphoblastic leukemia

Affiliations

Transcriptional regulatory program controlled by MYB in T-cell acute lymphoblastic leukemia

Xiaoman Shao et al. Leukemia. 2024 Dec.

Abstract

The transcription factor MYB is frequently upregulated in T-cell acute lymphoblastic leukemia (T-ALL), a hematological malignancy originating from T-cell precursors. Here, we demonstrate that MYB plays a crucial role by regulating genes essential for T-ALL pathogenesis. Integrative analysis reveals a long MYB isoform, ENST00000367814.8, which is dominantly expressed and confers a proliferative advantage in T-ALL cells. Rapid depletion of MYB via dTAG-mediated protein degradation affects a large number of genes, which can be classified into early response or late response genes based on their kinetics. Early response genes include many genes involved in hematopoiesis, such as TAL1, RUNX1, GATA3, IKZF2, and CXCR4. Their expression can be recovered at later time-points, suggesting the presence of a negative feedback loop mechanism. In contrast, late response genes, which are continuously downregulated after MYB depletion, includes many genes involved in cell proliferation as well as TAL1 targets, thereby affecting the cellular phenotype.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: All methods were performed in accordance with the relevant guidelines and regulations at our institute. This study does not involve any animal models or patient samples and thus does not require ethics approval.

References

    1. Girardi T, Vicente C, Cools J, De Keersmaecker K. The genetics and molecular biology of T-ALL. Blood. 2017;129:1113–23. - PubMed
    1. Pui CH, Carroll WL, Meshinchi S, Arceci RJ. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol. 2011;29:551–65. - PubMed
    1. van der Zwet CordoV, Canté-Barrett JCG, Pieters K, Meijerink R. JPP. T-cell acute lymphoblastic leukemia: a roadmap to targeted therapies. Blood Cancer Discov. 2021;2:19–31. - PubMed
    1. Patel AA, Thomas J, Rojek AE, Stock W. Biology and treatment paradigms in T Cell acute lymphoblastic leukemia in older adolescents and adults. Curr Treat Options Oncol. 2020;21:57. - PubMed
    1. Pui C-H, Evans William E. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354:166–78. - PubMed

MeSH terms

Substances